Discarded stem cells with a future?

Expert Opinion on Biological Therapy

Volumn 6, Issue 12, 2006, Pages 1251-1254

  Klingemann, Hans ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

Mesenchymal stem cells; Nuclear reprogramming; Placenta; Regenerative medicine; Stem cell; Umbilical cord blood; Wharton's jelly

Indexed keywords

BONE MARROW; CELL MATURATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYME CELL; PERINATAL PERIOD; PLACENTA; REVIEW; STEM CELL; STEM CELL TRANSPLANTATION; UMBILICAL CORD;

CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELLS; PLACENTA; TISSUE ENGINEERING; UMBILICAL CORD;

EID: 33845345225     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.6.12.1251     Document Type: Review

References (14)

1. CARPENTER MK, ROSLER E, RAO MS: Characterization and differentiation of human embryonic stem cells. Cloning Stem Cell (2003) 5:79-88.
2. WANG H-S, HUNG S-C, PENG S-T et al.: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells (2004) 22:1330-1337
3. WEISS ML, MEDICETTY S, BLEDSOE AR et al.: Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells (2006) 24:781-792.
4. ZHANG Y, LI C, JIANG X et al.: Human placenta-derived mesenchymal progenitor cells support culture expansion of long-term culture-initiating cells from cord blood CD34+ cells. Exp. Hematol. (2004) 32:657-664.
5. MIKI T, LEHMANN T, CAI H et al.: Stem cell characteristics of amniotic epithelial cells. Stem Cells (2005) 23:1549-1559.
6. KOGLER G, RADKE T F, LEFORT A et al.: Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp. Hematol. (2005) 33:573-583
7. LINKE A, MUELLER P, NURZYNSKA D et al.: Stem cells in the dog heart are self-renewing, clonogeneic, and multipotent and regenerate inftacted myocardium, improving cardiac function. Proc. Natl. Acad. Sci. USA (2005) 102:8966-8971.
8. DEANS RJ, MOSELEY AB: Mesenchymal stem cells: biology and potential clinical uses. Exp. Hematol. (2000) 28:875-884. • A balanced overview on the potential of MSCs.
9. LU LL, LIU YJ, YANG SG et al.: Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica (2006) 91:1017-1026. •• Excellent characterisation of umbilical matrix-derived MSCs compared with bone marrow-derived MSCs.
10. FRIEDMAN R, BETANCUR M, TUNCER H, BOISSEL L, CETRULO C, KLINGEMANN H: Co-transplantation of autologous umbilical cord matrix mesenchymal stem cells improves engraftment of umbilical cord blood in NOD/SCID mice. Blood (2006) (In Press).
11. DEMBINSKI JL, MARINI FC, STUDENY M, ZOMPETTA C, ANDREEFF M: Gene modified mesenchymal stem cells selectively engraft in stroma of ovarian carcinomas and control tumor growth. Cytotherapy (2006):888.
12. CAPLAN AI: Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. (2005) 11:1198-1211.
13. HOCHEDLINGER K, JAENISCH R: Nuclear reprogramming and pluripotency. Nature (2006) 441:1061-1067.
14. HOCHEDLINGER K, YAMADA Y, BEARD C, JAENISCH R: Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissue. Cell (2005) 121:465-477.